The pharmacokinetic-pharmacodynamic model of azithromycin for lipopolysaccharide-induced depressive-like behavior in mice.
A mechanism-based model was developed to describe the time course of lipopolysaccharide-induced depressive-like behavior and azithromycin pharmacodynamics in mice. The lipopolysaccharide-induced disease progression was monitored by lipopolysaccharide, proinflammatory cytokines, and kynrenine concent...
Main Authors: | Kun Hao, Qu Qi, Haiping Hao, Guangji Wang, Yuancheng Chen, Yan Liang, Lin Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3554664?pdf=render |
Similar Items
-
Naringin improves lipopolysaccharide-induced depression-like behaviors in mice
by: WU Chuan, et al.
Published: (2022-12-01) -
In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections
by: Davidson RJ
Published: (2019-03-01) -
Lipopolysaccharide Preconditioning Restricts Microglial Overactivation and Alleviates Inflammation-Induced Depressive-like Behavior in Mice
by: Haiping Yu, et al.
Published: (2023-03-01) -
Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis
by: Heather K. Knych, et al.
Published: (2022-12-01) -
Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
by: Haijing Yang, et al.
Published: (2022-04-01)